Qilibri has been acquired by SP2L (NaturAvignon Laboratory)
The owners of Qilibri, which include the co-founders, Day One Entrepreneurs & Partners, Pléiade Venture and Financière Saint-James, and business angels, have sold the company to SP2L (NaturAvignon Laboratory).
Qilibri is a French digital-native brand founded in 2019 by two experienced entrepreneurs, offering a holistic approach to weight loss through healthy pre-cooked meals delivery, professional dietary assistance and sports training. Qilibri uses algorithms to determine customers’ needs in order to maximize weight loss and lasting results, compared with standard offers. Qilibri’s objective is to redesign weight loss with a 360° offer based on a 100% customized program, which includes a qualitative nutrition offer designed by expert dieticians and a complete service offer via weekly professional dietary coaching, access to an online community and sport training, in partnership with a leading fitness club operator. Qilibri’s innovative, fully customized and efficient offer has enabled the company to quickly develop a community of approximately 200,000 people. Today, Qilibri is a brand recognized for its ability to leverage customers’ data, enabling to build a personalized and qualitative relationship throughout the program.
Founded in 2003, Groupe SP2L (Laboratoire NaturAvignon) offers safe, effective dietary supplements, health products and professional support to help seniors improve their health. Groupe SP2L comprises two brands: Laboratoire NaturAvignon, an emblematic brand in nutraceuticals for 20 years, and Blanche Bresson Institut, a digital brand of natural and organic food supplements.
Oaklins’ team in France acted as sell-side M&A advisor in the transaction.
Talk to the deal team
Related deals
Kaviari has received a minority investment from idiCo
Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreGroupe JVS has acquired Abelium Collectivités
Groupe JVS has acquired Abelium Collectivités, which was subsequently rebranded as Familea. The transaction, supported by CAPZA as a minority shareholder and Bpifrance, strengthens Groupe JVS’s strategy in the childcare and family services sector while expanding its offering to local public sector stakeholders.
Learn more